David Hallal

CIK 1457477 · Chief Executive Officer · last filed 2026-06-04

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$82.08M

Companies

5

Total Filings

112

Lifetime Open-Market Net

-$16.84M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
KLRS Director $4.33 $0 2 2026-06-04
SRRK Chief Executive Officer 1,844,034 $44.18 $81.47M -$3.97M 15 2026-04-20
iTeos Therapeutics, Inc. (ITOS) Delisted Director 0 $10.15 $0 -$3.94M 9 2025-08-29
SEER Director 355,128 $1.72 $610.8K $0 5 2024-06-14
Kalaris Therapeutics, Inc. (ALVR) Delisted Director 2,281,815 $9.81 $22.38M -$8.93M 15 2024-06-07

Recent Filings · Page 7 of 12

112 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2014-03-04 Grant (A) +6,000 $0
2014-02-10 Mixed +8,125 -$252.0K
2014-02-05 Sell (S) −3,119 -$481.7K
2014-01-31 Sell (S) −729 -$97.3K
2013-12-20 Mixed -$2.48M
2013-12-11 Mixed -$2.78M
2013-10-30 Mixed -$5.04M
2013-08-07 Sell (S) −730 -$85.3K
2013-08-01 Sell (S) −746 -$82.7K
2013-07-16 Mixed -$5.12M
Showing 6170 of 112
Page 7 of 12
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.